Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 489 Results

Page 35 of 49« First «...10 20 30...33 343536 37...40...»Last »

April 29, 2016

DBV Technologies Reports March 31, 2016 Cash Position

April 28, 2016

DBV Technologies Announces Filing of 2015 “Document de Référence” and 2015 Annual Report on Form 20-F

April 27, 2016

DBV Technologies to Attend Upcoming Investor Conferences

April 11, 2016

DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy

April 7, 2016

DBV Technologies Reports Full Year 2015 Financial Results

March 6, 2016

Additional Phase IIb Trial Results with Viaskin Peanut Presented at the 2016 AAAAI Meeting Continue to Support Treatment Safety, Efficacy and Compliance

March 4, 2016

DBV Technologies Announces Presentation from NIAID-sponsored CoFAR6 Phase II Trial Reaffirming Viaskin^® Peanut Safety and Efficacy

March 1, 2016

DBV Technologies to Attend Upcoming Investor Conferences and Events

February 25, 2016

DBV Technologies Announces Publication of Phase Ib Trial Results in the Journal of Allergy and Clinical Immunology (JACI) Supporting Safety and Tolerability of Viaskin^® Peanut

February 15, 2016

DBV Technologies Reports December 31, 2015, Cash Position

Page 35 of 49« First «...10 20 30...33 343536 37...40...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Your California Privacy Rights

Scroll to Top